Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence
Metabolite profiling is being increasing employed in the study of prostate cancer as a means of identifying predictive, diagnostic, and prognostic biomarkers. This review provides a summary and critique of the current literature. Thirty-three human case-control studies of prostate cancer exploring d...
Main Authors: | Kelly, R. S. (Author), Giovannucci, E. (Author), Mucci, L. A. (Author), Vander Heiden, Matthew G. (Contributor) |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT (Contributor) |
Format: | Article |
Language: | English |
Published: |
American Association for Cancer Research (AACR),
2018-07-11T20:07:11Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
by: Kelechi Njoku, et al.
Published: (2020-07-01) -
High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis
by: Shi-ang Qi, et al.
Published: (2021-06-01) -
Prostate Cancer: Prognosis and Recurrence
by: Luciano A. Favorito
Published: (2013-06-01) -
MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer
by: Gloria Bertoli, et al.
Published: (2016-03-01) -
Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes
by: Stefano Salciccia, et al.
Published: (2021-04-01)